Disclosure 0002043395-26-000012-2

SEC FORM 4

$146,160.00

FENNEC PHARMACEUTICALS INC. (FENC)

Sale of 12,000 shares at $12.18 per share.

Reporting Person Sayad Pierre Sargis · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 31, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0002043395-26-000012 · filed 2026-08-31 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "FENNEC PHARMACEUTICALS INC. (FENC)." Disclosed 2026-08-31. https://desqlong.com/cards/0002043395-26-000012-2 (retrieved 2026-09-26).